XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 123 filers reported holding XENON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $397,042 | +12.2% | 11,623 | +26.4% | 0.00% | 0.0% |
| Q2 2023 | $353,931 | +6.3% | 9,193 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $333,098 | -10.5% | 9,307 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $372,180 | +54.4% | 9,439 | +41.6% | 0.00% | +100.0% |
| Q3 2022 | $241,000 | +18.7% | 6,667 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $203,000 | -1.5% | 6,667 | -1.0% | 0.00% | 0.0% |
| Q1 2022 | $206,000 | -31.1% | 6,733 | -29.6% | 0.00% | 0.0% |
| Q4 2021 | $299,000 | +367.2% | 9,565 | +127.7% | 0.00% | – |
| Q3 2021 | $64,000 | -15.8% | 4,201 | +2.7% | 0.00% | – |
| Q2 2021 | $76,000 | +4.1% | 4,091 | 0.0% | 0.00% | – |
| Q1 2021 | $73,000 | – | 4,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |